Search Results - "WELLS, Charles D"
-
1
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
Published in The Lancet (British edition) (07-05-2011)“…Summary Background In accordance with WHO guidelines, people with HIV infection in Botswana receive daily isoniazid preventive therapy against tuberculosis…”
Get full text
Journal Article -
2
HIV Infection and Multidrug-Resistant Tuberculosis—The Perfect Storm
Published in The Journal of infectious diseases (15-08-2007)“…Background. Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global epidemic, with ∼ 425,000 new cases estimated to occur annually. The global…”
Get full text
Journal Article -
3
Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes Among a Predominantly HIV-Infected Cohort of Adults with Tuberculosis from Botswana
Published in Clinical infectious diseases (15-06-2009)“…Background. We explored the association between antituberculosis drug pharmacokinetics and treatment outcomes among patients with pulmonary tuberculosis in…”
Get full text
Journal Article -
4
Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand
Published in Emerging infectious diseases (01-07-2007)“…Antiretroviral therapy (ART) is lifesaving in patients with advanced HIV infection, but the magnitude of benefit in HIV-infected patients receiving…”
Get full text
Journal Article -
5
Digital health technologies and adherence to tuberculosis treatment
Published in Bulletin of the World Health Organization (01-05-2021)Get full text
Journal Article -
6
Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis
Published in American journal of respiratory and critical care medicine (01-08-2000)“…We conducted a placebo-controlled, double-blind, randomized study to evaluate the microbiological efficacy and safety of inhaled tobramycin for treatment of…”
Get full text
Journal Article -
7
HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study
Published in BMC infectious diseases (13-04-2009)“…In Southeast Asia, HIV-infected patients frequently die during TB treatment. Many physicians are reluctant to treat HIV-infected TB patients with…”
Get full text
Journal Article -
8
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Published in The European respiratory journal (01-06-2013)“…Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality,…”
Get full text
Journal Article -
9
Childhood TB epidemiology and treatment outcomes in Thailand: a TB active surveillance network, 2004 to 2006
Published in BMC infectious diseases (18-07-2008)“…Of the 9.2 million new TB cases occurring each year, about 10% are in children. Because childhood TB is usually non-infectious and non-fatal, national programs…”
Get full text
Journal Article -
10
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
Published in The European respiratory journal (01-05-2015)“…Multidrug-resistant tuberculosis (MDR-TB) is a serious obstacle to TB control [1]. The disproportionately negative outcomes among patients with drug resistance…”
Get full text
Journal Article -
11
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Published in The New England journal of medicine (07-06-2012)“…In this report on the treatment of multidrug-resistant (MDR) tuberculosis, the authors found that delamanid, a novel anti-TB medication, led to more rapid…”
Get full text
Journal Article -
12
Evaluating the potential impact of the new global plan to stop TB : Thailand, 2004-2005
Published in Bulletin of the World Health Organization (01-08-2007)“…WHO's new Global Plan to Stop TB 2006-2015 advises countries with a high burden of tuberculosis (TB) to expand case-finding in the private sector as well as…”
Get full text
Journal Article -
13
Delamanid for Extensively Drug-Resistant Tuberculosis
Published in The New England journal of medicine (16-07-2015)“…Therapeutic options for extensively drug-resistant tuberculosis infection are limited. In this post-hoc analysis, a new drug, delamanid, shows some activity in…”
Get full text
Journal Article -
14
HIV-associated TB in An Giang Province, Vietnam, 2001-2004: epidemiology and TB treatment outcomes
Published in PloS one (06-06-2007)“…Mortality is high in HIV-infected TB patients, but few studies from Southeast Asia have documented the benefits of interventions, such as co-trimoxazole (CTX),…”
Get full text
Journal Article -
15
Pan-tuberculosis regimens: re-framing the argument
Published in The lancet respiratory medicine (01-07-2018)Get full text
Journal Article -
16
Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis
Published in The international journal of tuberculosis and lung disease (01-10-2015)Get full text
Journal Article -
17
Multidrug-resistant tuberculosis detection, Latvia
Published in Emerging infectious diseases (01-09-2005)“…To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory…”
Get full text
Journal Article -
18
Rigorous Clinical Trial Design in Public Health Emergencies Is Essential
Published in Clinical infectious diseases (17-04-2018)“…Randomized clinical trials are the most reliable approaches to evaluating the effects of new treatments and vaccines. During the 2014-2015 West African Ebola…”
Get full text
Journal Article -
19
Time to sputum culture conversion in multidrug-resistant tuberculosis : Predictors and relationship to treatment outcome
Published in Annals of internal medicine (02-05-2006)“…Conversion of sputum mycobacterial cultures from positive growth to negative growth of Mycobacterium tuberculosis in patients with pulmonary tuberculosis (TB)…”
Get full text
Journal Article -
20
Reply to Jacob and Colebunders
Published in Clinical infectious diseases (31-08-2018)Get full text
Journal Article